Co-expression of bovine growth hormone (GH) and human GH antagonist genes in transgenic mice

Endocrinology

Volumn 138, Issue 2, 1997, Pages 851-854

  Chen, Nian Yi ^a   Chen, Wen Y ^a   Striker, Liliane J ^b   Striker, Gary E ^b   Kopchick, John J ^a  

^a OHIO UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE ANTAGONIST; HORMONE ANTAGONIST; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DWARFISM; FEMALE; GENE EXPRESSION; GLOMERULOSCLEROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0031053537     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.2.5036     Document Type: Article

References (11)

1. Goodman HM 1993 Growth hormone and metabolism. In: Schreibman MP, Scanes CG, Pang PKT (eds) The endocrinology of growth, development, and metabolism in vertebrates. Academic Press Inc. San Diago, CA, pp 93-115.
2. Chen WY, White MH, Wagner TK, Kopchick JJ 1991 Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology 129:1402-1407.
3. Chen WY, Chen N, Yun J, Wagner TK, Kopchick JJ 1994 In vitro and in vivo studies of antagonistic effects of human growth hormone analogs. J Bio Chem 269:15892-15897.
4. Okada S, Chen WY, Wiehl P, Kelder H, Goodman HM, Guller S, Sonenberg M, Kopchick JJ 1992 A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F422A preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes. Endocrinology 130:2284-2290.
5. Wang X, Xu B, Sousa SC, Kopchick JJ 1994 Growth hormone (GH) induces tyrosine-phosphorylated proteins in mouse L cells that express recombinant GH receptors. Proc Natl Acad Sci USA 91:1391-1395.
6. Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer K, Brinster R, Striker GE 1988 Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor 1. Am J Pathol 131:398-403.
7. Chen N, Chen WY, Bellush L, Yang C-W, Striker LJ, Striker CE, Kopchick JJ 1995 Effects of STZ treatment in GH and GH-antagonist transgenic mice. Endocrinology 136:660-667.
8. Dunger DB, Edge JA, Pal K, Taylor AM, Holly JMP, Mathews DR 1991 Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes. Acta Padiat Scand [Suppl] 377:60-77.
9. Alzaide AA, Melton III, LJ, Dinneen, SF, Rizza RA 1994 The role of growth hormone in the development of diabetic retinopathy. Diabetes Care 17:531-534.
10. Flyvbjerg A, Marshall SM, Krystyk J, Hansen KW, Harris AG, Ørskov H 1992 Octreotide administration in diabetic rats: Effects on renal hypertrophy and urinary albumin excretion. Kid Inter 41:805-812.
11. Anthony L, Johnson D, H&e K, Shaff M, Winn S, Krozely M, Oates J 1993 Somatostatin analog phase 1 trials in neuroendocrine neoplasm. Acta Oncologica 32:217-223.